Eosinophil peroxidase catalyzes bromination of free nucleosides and double-stranded DNA.
Chronic parasitic infections are a major risk factor for cancer development in many underdeveloped countries. Oxidative damage of DNA may provide a mechanism linking these processes. Eosinophil recruitment is a hallmark of parasitic infections and many forms of cancer, and eosinophil peroxidase (EPO), a secreted hemoprotein, plays a central role in oxidant production by these cells. However, mechanisms through which EPO may facilitate DNA oxidation have not been fully characterized. Here, we show that EPO effectively uses plasma levels of bromide as a cosubstrate to brominate bases in nucleotides and double-stranded DNA, forming several stable novel brominated adducts. Products were characterized by HPLC with on-line UV spectroscopy and electrospray ionization tandem mass spectrometry (LC/ESI/MS/MS). Ring assignments for brominated purine bases as their 8-bromo adducts were identified by NMR spectroscopy. Using stable isotope dilution LC/ESI/MS/MS, we show that while guanine is the preferred purine targeted for bromination as a free nucleobase, 8-bromoadenine is the major purine oxidation product generated following exposure of double-stranded DNA to either HOBr or the EPO/H(2)O(2)/Br(-) system. Bromination of nucleobases was inhibited by scavengers of hypohalous acids such as the thioether methionine, but not by a large molar excess of primary amines. Subsequently, N-monobromoamines were demonstrated to be effective brominating agents for both free nucleobases and adenine within intact DNA. A rationale for selective modification of adenine, but not guanine, in double-stranded DNA based upon stereochemical criteria is presented. Collectively, these results suggest that specific brominated DNA bases may serve as novel markers for monitoring oxidative damage of DNA and the nucleotide pool by brominating oxidants.
Shen
Z
Z
Department of Cell Biology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Mitra
S N
SN
Wu
W
W
Chen
Y
Y
Yang
Y
Y
Qin
J
J
Hazen
S L
SL
D000225:Adenine / Q000031:analogs & derivatives* / Q000378:metabolism; D000818:Animals; D001959:Bromates / Q000378:metabolism; D001966:Bromine / Q000097:blood / Q000378:metabolism; D002384:Catalysis; D018736:DNA Adducts / Q000378:metabolism*; D003849:Deoxyguanosine / Q000031:analogs & derivatives / Q000378:metabolism; D003853:Deoxyribonucleosides / Q000378:metabolism*; D047209:Eosinophil Peroxidase; D004804:Eosinophils / Q000201:enzymology* / Q000378:metabolism; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism; D013058:Mass Spectrometry; D019906:Nuclear Magnetic Resonance, Biomolecular; D009692:Nucleic Acid Heteroduplexes / Q000378:metabolism; D016877:Oxidants / Q000378:metabolism; D010084:Oxidation-Reduction; D010544:Peroxidases / Q000378:metabolism*; D011684:Purine Nucleosides / Q000737:chemistry / Q000378:metabolism; D013552:Swine
D001959:Bromates; D018736:DNA Adducts; D003853:Deoxyribonucleosides; D009692:Nucleic Acid Heteroduplexes; D016877:Oxidants; D011684:Purine Nucleosides; C027055:8-bromoadenine; D006861:Hydrogen Peroxide; D047209:Eosinophil Peroxidase; D010544:Peroxidases; D003849:Deoxyguanosine; C027664:hypobromous acid; D000225:Adenine; D001966:Bromine